Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development
Psychedelic Medicine September 6, 2023 Marc J. Weintraub, Jessica K Jeffrey, Charles S. Grob et al. 4 citations
The trial will provide preliminary data on the feasibility, safety, acceptability, and psychosocial effects of PA-CBT. Results will inform randomized clinical trials to test the effects of PA-CBT for patients with depression and other mental health conditions, as well as hypotheses concerning mediating mechanisms at the cognitive and affective levels. ClinicalTrials.gov ID: NCT05227612.
DOI: 10.1089/psymed.2023.0018 (opens in new tab)
Full text (opens in new tab)
Psilocybin
Major depressive disorder
Cognitive behavioral therapy
Psychotherapist
+3